Technical Analysis for OKYO - OKYO Pharma Limited

Grade Last Price % Change Price Change
C 1.20 1.69% 0.02
OKYO closed up 1.69 percent on Friday, November 1, 2024, on 52 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Up Up

Date Alert Name Type % Chg
Spinning Top Other 0.00%
NR7 Range Contraction 0.00%
Narrow Range Bar Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Up 3 Days in a Row Strength 0.00%
Calm After Storm Range Contraction 1.69%
Inside Day Range Contraction 1.69%
New Uptrend Bullish 3.00%
Calm After Storm Range Contraction 3.00%
Upper Bollinger Band Walk Strength 3.00%

   Recent Intraday Alerts

Alert Time
Possible NR7 about 23 hours ago
Rose Above Previous Day's High 1 day ago
Up 3% 1 day ago
Up 2% 1 day ago
Up 1% 1 day ago

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

OKYO Pharma Limited (Nasdaq: OKYO, LSE: OKYO) is a biotechnology company developing next-generation therapeutics to improve the lives of patients suffering from inflammatory eye diseases and ocular pain. OKYO’s research program is focused on a novel G Protein-Coupled Receptor, or GPCR, which OKYO believes plays a key role in the pathology of these inflammatory eye diseases of high unmet medical need. OKYO’s therapeutic approach is focused on targeting inflammatory and pain modulation pathways that drive these conditions. The Company is presently developing OK-101, its lead preclinical product candidate, for the treatment of dry-eye disease “DED”. The Company also plans to evaluate its potential in benefiting patients with ocular neuropathic pain, uveitis and allergic conjunctivitis.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Clinical Medicine Immunology Pain Eye Diseases Inflammatory Uveitis Allergic Conjunctivitis Dry Eye Disease Conjunctivitis Measles Treatment Of Dry Eye Disease

Is OKYO a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 2.12
52 Week Low 0.8075
Average Volume 231,959
200-Day Moving Average 1.30
50-Day Moving Average 1.06
20-Day Moving Average 1.08
10-Day Moving Average 1.14
Average True Range 0.10
RSI (14) 57.98
ADX 32.67
+DI 33.35
-DI 5.92
Chandelier Exit (Long, 3 ATRs) 1.05
Chandelier Exit (Short, 3 ATRs) 1.25
Upper Bollinger Bands 1.25
Lower Bollinger Band 0.91
Percent B (%b) 0.85
BandWidth 31.10
MACD Line 0.04
MACD Signal Line 0.02
MACD Histogram 0.0151
Fundamentals Value
Market Cap 39.88 Million
Num Shares 33.2 Million
EPS -0.61
Price-to-Earnings (P/E) Ratio -1.97
Price-to-Sales 0.00
Price-to-Book 14.11
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.28
Resistance 3 (R3) 1.27 1.25 1.26
Resistance 2 (R2) 1.25 1.23 1.25 1.26
Resistance 1 (R1) 1.22 1.22 1.24 1.23 1.25
Pivot Point 1.20 1.20 1.20 1.20 1.20
Support 1 (S1) 1.17 1.18 1.19 1.18 1.15
Support 2 (S2) 1.15 1.17 1.15 1.14
Support 3 (S3) 1.12 1.15 1.14
Support 4 (S4) 1.13